Cancer

Items 821-830 of 979

per page
Set Descending Direction
  1. SAG Analog (LowTox)
    CAS  1401532-78-2
    AG-CR1-3517
    AG-CR1-3517-M0011 mg
    CHF 295.00
    SAG Analog (LowTox)
  2. Salicin
    CAS  138-52-3
    CDX-S0001
    CDX-S0001-G02525 g
    CHF 102.00
    CDX-S0001-G100100 g
    CHF 305.00
    Salicin
  3. Salidroside
    CAS  10338-51-9
    CDX-S0092
    CDX-S0092-M02525 mg
    CHF 177.00
    CDX-S0092-M100100 mg
    CHF 530.00
    CDX-S0092-M500500 mg
    CHF 2'117.00
    Salidroside
  4. Salinosporamide A
    CAS  437742-34-2
    AG-CN2-0444
    AG-CN2-0444-C100100 µg
    CHF 160.00
    AG-CN2-0444-M0011 mg
    CHF 720.00
    AG-CN2-0444-M0055 mg
    CHF 2'500.00
    AG-CN2-0444-M05050 mgINQ

    BULK available!
    Research Use Only (RUO). NOT ALLOWED FOR USE IN HUMANS.

    Learn more about Salinosporamide A

    Salinosporamide A
  5. SANT-2
    CAS  329196-48-7
    AG-CR1-3514
    AG-CR1-3514-M0011 mg
    CHF 50.00
    AG-CR1-3514-M0055 mg
    CHF 115.00
    SANT-2
  6. Saquayamycin B1
    CAS  99260-68-1
    BVT-0382
    BVT-0382-C500500 µg
    CHF 115.00
    BVT-0382-M0011 mg
    CHF 180.00
    BVT-0382-M0055 mg
    CHF 540.00
    Saquayamycin B1
  7. SAR-020106
    CAS  1184843-57-9
    SYN-1189
    SYN-1189-M0011 mg
    CHF 270.00
    SYN-1189-M0055 mg
    CHF 546.00
    SYN-1189-M01010 mg
    CHF 858.00
    SYN-1189-M100100 mgINQ
    SYN-1189-M05050 mgINQ
    SAR-020106
  8. SAR-131675
    CAS  1092539-44-0
    SYN-1165
    SYN-1165-M0011 mg
    CHF 270.00
    SYN-1165-M0055 mg
    CHF 546.00
    SYN-1165-M01010 mg
    CHF 858.00
    SYN-1165-M05050 mgINQ
    SYN-1165-M100100 mgINQ
    SAR-131675
  9. Sarcophine
    CAS  55038-27-2
    BVT-0305
    BVT-0305-M0022 mg
    CHF 115.00
    BVT-0305-M01010 mg
    CHF 475.00
    Sarcophine
  10. Sauchinone
    CAS  177931-17-8
    AG-CN2-0032
    AG-CN2-0032-M0011 mg
    CHF 40.00
    AG-CN2-0032-M0055 mg
    CHF 120.00
    Sauchinone

Items 821-830 of 979

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.